http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022031509-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022031509-A |
| titleOfInvention | A composition for suppressing androgen-dependent or independent prostate cancer cells and a pharmaceutical preparation for prostate cancer containing the same. |
| abstract | PROBLEM TO BE SOLVED: To suppress the activation of an androgen receptor, to suppress the growth of androgen-dependent or independent prostate cancer, and to exert its action even if AR-V7 is expressed. Provided are a composition for suppressing androgen-dependent or independent prostate cancer cells that suppresses and is effective against an anticancer drug-resistant cell line, and a pharmaceutical preparation for prostate cancer using the same. SOLUTION: The composition for suppressing androgen-dependent or independent prostate cancer cells has a chemical formula (1). [Chemical 1] (X- is a hydrocarbon aromatic ring group or an aromatic heterocyclic group, Y 1- and Y 2- are both or one of a hydrocarbon aromatic ring group or an aromatic heterocyclic group, the other is a hydrogen atom, and Z = is a bonded carbon. An atom or functional group that forms or forms a ketone group, a thioketone group, an imino group, or an oxime group together with an atom, Y 3 -is a hydrogen atom, a perhalogenohydrocarbon group, etc.) and is represented by α, β-saturated or unsaturated. Contains a ketone derivative or a pharmaceutically acceptable salt thereof. Pharmaceutical formulations for prostate cancer contain this composition. [Selection diagram] None |
| priorityDate | 2016-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.